Highlights•Long-term risks of MACCE in primary preventive statin therapy.•Using statin type, dose, adherence and diabetes as time-dependent variables.•Incident drug-treated MACCE is still very common in primary preventive patients.•Adherence is no longer associated with drug-treated MACCE in statin-persistent patients.